Проблема оксида азота в неврологии

Сосунов А.А. Оксид азота как межклеточный посредник // Соровский образовательный журнал. - 2000. - Т.6. - С. 27-34.

С.Р. Гиляревский. Применение нитратов при лечении сердечно-сосудистых заболеваний: роль изосорбида мононитрата // Трудный пациент. - 2006. - № 11.

Стокле Ж.-К., Мюлле Б., Андрианцитохайна Р., Клещев А. Гиперпродукция оксида азота в патофизиологии кровеносных сосудов. Биохимия. 1998; 63 (7): 976-83.

Торчинский Ю.M. // Сера в белках. - M.: Наука, 1977. - 302 с.

Турпаев К.Т. // Молек. Биол. 1998. 32, № 4. С. 581-591.

Херман В.М., Бон-Щлчевский В.Дж., Кунту Г. Инфузионная терапия актовегином у пациентов с первичной дегенеративной деменцией типа Альцгеймера и мульти-инфарктной деменцией (результаты проспективного плацебо-контролируемого двойного слепого исследования у пациентов, находящихся в условиях стационара) // РМЖ. 2002. Т. 10. № 15. С. 658-663.

Хилько В.А. (1998) Диагностика и лечение хронической цереброваскулярной недостаточности при атеросклерозе сонной артерии. Вестник РАМН, 1: 30-34.

Шевченко О.П., Шевченко А.О. Статины ингибиторы ГМГ-КоА-редуктазы. - Москва: Реафарм, 2003.

Шестакова М.В. (2001) Дисфункция эндотелия - причина или следствие метаболического синдрома? Рос. мед. журнал, 2: 88-92.

Шимановский Н.Л., Гуревич К.С. Роль оксида азота в механизмах действия лекарственных веществ // Международный мед. журн. - 2000. - Т. 6, № 1. - С. 104-107.

Шмырёв В.И., Остроумова О.Д., Боброва Т.А. Возможности препарата актовегин в профилактике и лечении деменции // РМЖ. 2003. Т. 11. № 4. C. 216-220.

Шток В.Н., Федорова Н.В. Лечение паркинсонизма. М., 1997.

Щербакова И.В., Клюшник Т.П., Ермакова С.А., Ефремова Н.М., Скворцова В.И. Взаимосвязь воспалительных и аутоиммунных факторов при ишемическом инсульте. Журнал неврологии и психиатрии им. С.С. Корсакова, вып. 4, 2001.

Ю.Ю. Тюрина, Т.В. Соколова и др. «Ингибирование Na,K-аденозинтрифосфатазы под действием глутамата в синаптосомах коры мозга. Защитный эффект токоферола и супероксиддисмутазы». (Журнал эволюционной биохимии и физиологии, 1998, Т.34, N3, с. 325-332).

Я.В. Богданов, В.Р. Богданов, К.Г. Громов и др. «Возможное участие моноксида азота в патогенезе клещевого энцефалита» (Санслужба г. Кемерово. Прошлое, настоящее, будущее, Кемерово, 1997).

Яворська В.О., Грицай Н.М., Мохамед А.М. (2004) Роль системи гемостазу при порушенні мозкового кровообігу. КНИГА, Київ, 192 с.

Янсен В., Брукнер Г.В. Лечение хронической цереброваскулярной недостаточности с использованием драже актовегин-форте (двойное слепое плацебо-контролируемое исследование) // РМЖ. 2002. Т. 10. № 12-13. С. 543-546.

Яхно Н.Н., Лавров А.Ю. Изменения центральной нервной системы при старении // Нейродегенеративные болезни и старение (руководство для врачей) / под ред. И.А. Завалишина, Н.Н. Яхно, С.И. Гавриловой. М., 2001. С. 242-261.

Яхно Н.Н., Захаров В.В. Нарушение памяти в неврологической практике // Неврологический журнал. 1997. Т. 4. С. 4-9.

A pivotal role of nitric oxide in endothelial cell dysfunction / M.S. Goligorsky [et al.] // Acta Physiol. Scand. 2000. Vol. 168(1). P. 33-40.

A. Enhanced oxidative stress in iNOS-deficient mice after-traumatic brain injury: support for a neuroprotective role of-iNOS / H. Bayir, V. E. Kagan, G. G. Borisenko et al. // J. Cer-eb. Blood Flow Metab. - 2005. - Vol. 25. - P. 673-684.

Abe J.I., Berk B.C. Reactive oxigene species of signal transduction in cardiovascular disease. Trends Cardiovasc Med 1998; 8: 59-64.

Abman S.H., Chafield B.A., Eoll S.L. et al. Role of endothelium- derived relaxing factor during transition of pulmonary circulation at birth. Am J Physiol 1990; 259:H1921-H1927.

Abrams J. Nitroglycerin and long-acting nitrates in clinical practice // Am J Med 1983; 74:85-94.

Abu-Soud H. M., Wang I, Rouscean D. L. еt al. // J. Biol. Chem. 1995. 270. P. 22997-23006.

Achan M., Brodhead M., Malaki G. еt al. Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans. Arterioscler Thromb Vase Biol 2003; 23:8:1455-1459.

Adams H.P., Jr. Adams R.J., Brott T. et al.; Stroke Council of the American Stroke Association (2003) Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association. Stroke, 34(4): 1056-1083.

Adorns M.R., McCredie R., Jessup W. еt al. Oral L-arginine improves endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in joung men with coronary artery disease. Atherosclerosis 1997; 129:261-269.

Aggarwal B.B., Mehta K. // Meth. Enzymol. - 1996. - Vol. 269.

P. 166-171.

Agulo L., Garcia-Dorado D., Inserte J. L-arginine limits myocardial cell death secondary to hypoxia-reoxygenation by cGMP-dependent mechanism. Am J Physiol 1999; 776:H1574-H158O.

Ahonen M. (2002) Acta Univers. Tamperens., 885, 1-101.

Akhras F., Jackson G. Efficacy of nifedipine and isosorbide mononitrate in combination with atenolol in stable angina // Lancet 1991; 338:1036-1039.

Akiyama K., Gluckman T.L., Terhakopian A., Jinadasa P.M., Narayan S., Singaswamy S., Massey B. 3rd; Bing R.J. (1997) Tissue Cell 29, 733-743.

Albers G.W., Goldberg M.P., Choi D.W. Do NMDA-Antagonists Prevent Neuronal Injury? Yes // Archives of Neurology. - 1992. - Vol. 49. - P. 418-420.

Aldskogius H. Lakartidningen 2000 Jul 26; 9 (30-31):3358-3362 Related Articles, Books.

Alhenc-Gelas F., Tsai S.J., Callahan K.S. et al., Stimulation of prostaglandin formation by vasoactive mediators in cultured human endothelial cells. Basic Res Cardiol 1982; 24:723-742.

Allison A. Brown., Frank B Hu Dietary modulation of endothelial function: implications for cardiovascular disease. American Journal of Clinical Nutrition, 2001; 73 №4 673-686.

Al-Mustafa А.Н. Stability and transnitrosation efficacy of S-nitrosothiols in biological model systems by MS Biological Science.Dusseldorf 2001//diss.ub.uni-duesseldorf.de/ebib/diss/ffle?dissid=289.

AL-SA'doni Н., Ferro A. // Clinical. Science. - 2000. - 98, N 5. - P. 507-520.

Ambrose J.A, Tannenhaum M.A, Alexopoulos D. et al. Angiographic progression of coronary artery disease ana the development of myocardial infarction. J. Amer. Coll. Cardiol. 1988; 92: 657-671.

American Psychiatry Association. Diagnostic and Statistical Manual of Mental Disorders. 4th Ed. // Washington: American Psychiatry Association. 1994.

Amici S., Reed B., Mungas D. et al. Mild cognitive impairment with and without lacunes // 2nd Congress of the International Society for Vascular Behavioural and Cognitive Disorders (Vas-Cog). Abstract book. Florence, 2005. P. 21.

Angard E. // Lancet. - 1994. - Vol. 343, N 14. - P. 1199-1206.

Antioxidant properties and Clinical implications of alpha-lipoic acid / L. Packer, E.H. Witt, H.J. Trischler. et al. // Biothiols in health and disease / L. Packer, E. Cadenas,-(eds.) - Marcel Dekker, USA, 1995. - P. 479-516.

Armstrong P.W., Moffat J.A., Marks G.S. Arterial-venous nitroglycerin gradient during intravenous infusion in man // Circulation 1982; 66:1273-1276.

Auchus A., Chen C. Vascular MCI: exploratory experience with definition and course // 2nd Congress of the International Society for Vascular Behavioural and Cognitive Disorders (Vas-Cog). Abstract book. Florence, 2005. P. 26.

Auer J., Berent R., Mayr H., Kirchgatterer A., Eber B. Abteilung [Antiischemia effect of estrogens]. [Article in German] Z Kardiol 2000; May; 89(5):434-41.

Augusto O., Bonini M.G., Amanso A.M. et al. // Free Radic. Biol. Med. - 2002. - 32, N 9. - P. 841-859.

Austin M.A. Plasma triglyceride and coronary heart disease. Artcrioscler. Thromb. 1991; 11: 2-14.

Azen S.P., Qian D., Mack W.J. et al. Effect of supplementary antioxidant vitamin intake on carotid arterial wall intima-media thickness in a controlled clinical trial of cholesterol lowering. Circulation, 1996: 94: 2369-2372.

Azurna H., Ishikawa M., Sekizaki S. Endothelium-dependent inhibition of platelet aggregation. Brit. J. Pharmacol. 1986; 88: 411-415.

Baas D., Prufer K., Ittel M.E., Kuchler-Bopp S., Labourdette G., Sarlieve L.L. and Brachet P. (2000) Glia, 31, 59-68.

Bakker F.C., Klijn C.J.M., Jennekens-Schinkel A. et al. Cognitive impairment in patients with carotid artery occlusion and ipsilateral transient ischemic attacks // J. Neurol. 2003. Vol. 250. P. 1340-1347.

Ballard C., Rowan E., Stephens S. et al. Prospective follow-up study between 3 and 15 months after stroke: Improvements and decline in cognitive function among dementia-free stroke survivors >75 years of age // Stroke. 2003. Vol. 34. P. 2440-2444.

Ballou D.P., Zhao Y., Brandish P.E., Marietta M.A. // Proc. Natl. Acad. Sci. USA. - 2002. - 99, N 19. - P. 12097-12101.

Banga J, Jacotot B, Pfister P et al. Long-term fluvastatin treatment of hypercholesterolemia: a 52-week multicenter safety and efficacy study. Am J Med, 1994; 96:87-93.

Bank N.R., Aynedjian H.S. Role of EDRF (nitric oxide) in diabetic renal hyperfiltration // Kidney Int. - 1993. - Vol. 43, № 9. - P. 1306-1312.

Barker W.W., Luis C.A., Kashuba A. et al. Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank //Alzheimer Dis Assoc Disord. 2002. V.16. P. 203-212.

Barnes J., Karn М. Nuclear factor kappa В - a pivotal transcription factor in chronic inflammatory diseases // N. Eng. J. Med. - 1997. - Vol. 336. - P. 1066-1071.

Bartberger M.D., Fukuto J.M., Houk K.N. // PNAS. - 2001. - 98, N 5. - P. 2194-2198.

Bassenge E. (1991) Antiplatelet effects of endothelium-derived relaxing factor and nitric oxide donors. Eur. Heart J., 12 (Suppl. E): 12-15.

Bauer R., Fritz H. Pathophysiology of traumatic injury in the developing brain: an introduction and short up-date // Exp. Toxicol. Pathol. - 2004. - Vol. 56. - P.65-73.

Bazan, N.G., de Turco E.B.R. & Allan, G. (1995) J. Neurotrauma 12, 791-814.

Beckman J. // Oxygen'99 Sunrise Free Radical School. - P. 1-13.

Beckman J.S., Carson M., Smith C.D., Koppenol W.H.I/ Nature. - 1993. - 364, N 6438. - P. 584-589.

Beckman J.S. OONO-: Rebounding from nitric oxide. Circulat Res 2001; 89:295-297.

Been L., Rajagopalan M., Tarpey M. et al. A role of superoxide in angiotensin 2, but not catecholamine-induced hypertension. Circulation 1997; 95:588-593.

Bemiss C.J., Mahon B.D., Henry A., Weaver V. and Cantorna M.T. (2002) Arch. Biochem. Biophys., 402, 249-254.

Benatar D., Hall V., Reddy S., Gheorghiade M. Clinical and neurohormonal effects of nicardipine hydrochloride in patients with severe chronic heart failure receiving angiotensin-converting enzyme inhibitor therapy // Am J Ther 1998; 5:25-32.

Bennett D.A., Wilson R.S., Schneider J.A. et al. Natural history of mild cognitive impairment in older persons // Neurology. 2002. Vol. 59. P. 198-205.

Benzuly K.H., Padgett R.C., Koul S. et al. Functional improvement precedes structural regression of atherosclerosis. Circulation, 1994; 89: 1810-1818.

Berk В.С., Alexander R.W. Biology of the vascular wall in hypertension. In: Renner R.M., ed. The Kidney. Philadelphia: W.B. Saunders, 1996: 2049-2070.

Berkels R., Egink G., Marsen T.A. Bartels H., Roesen R., Klaus W. Nifedipine increases endothelial nitric oxide bioavailability by antioxidative mechanisms. Hypertension 2001; Feb; 37(2):240-5.

Biagas K.V., Uhl M.W., Schiding J.K. et al.J.Neurotrauma. - 1992. - № 9. - P.363-371.

Billar N.R. //Ann. Surg. - 1995. - Vol. 221, N 4. - P. 339-349.

Bind L., Granstam C.O., Millgard J. Engothelium-dependent vasodilatation in hypertension: a review. Blood Pres 2000;9:4-15.

Blackwell G.J. & Flower R.J. 1983 Br. Med. Bull. 39, 260-264.

Blann A.D., Belgore F.M., Constans J. et al. Plasma vascular endothelial growth factor and its receptor Flt-1 in patients with hyperlipidemia and atherosclerosis and the effects of fluvastatin or fenofibrate. Am J Cardiol 2001; 87:1160-3.

Blann A.D., Tarberner D.A. A reliable marker of endothelial cell disfunction: does it exist? Brit. J. Haematol. 1995; 90: 244-248.

Blass J.B. Metabolic dementias // Aging of the brain and dementia. Aging. V.13. Ed. By L.Amaducci et al. N.Y.: Raven Press. 1980. P. 261-170.

Bocchi E.A., de Moraes A. V., Esteves A. et al. L-arginine reduces heart rate and improves hemodynamics in severe congestive heart failure. Clin Cardiol 2000; 23:205-210.

Boese M., Keese M.A., Becker K. et al. // Ibid. - 1997. - 272, N 35. - P. 21767-21773.

Boese M., Mordvintcev P.I., Vanin A.F. еt al. // J. Biol. Chem. - 1995. - 270, N 49. - P. 29244-29249.

Boet R., Mee E. Neurosurgery 2000 Sep; 47(3):602-6; discussion 606-7.

Bogaert M.G. Organic nitrates in therapy: a 100-year development // Verh K Acad Geneeskd Belg 1984; 46(1):53-61.

Bogaert M.G. Pharmacokinetics of organic nitrates in man: an overview // Eur Heart J 1988; 9:Suppl A:33-37.

Boger R.H., Bode-Boger S.M., Brandes R.P. et al. Dietary L-arginine reduces the progression of atherosclerosis in cholesterol-fed rabbits. Circulation 1997;96:1282-1290.

Boger R.Н., Bode-Boger S.M., Thiele W. еt al. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arteriol occlusive olisease. Circulation 1997; 95:2068-2074.

Bogousslavsky J. The global stroke initiative, setting the context with the International Stroke Society // J Neurol Sciences. 2005. V. 238. Supp l.1. IS. 166.

Boh M., Opolski G., Poredos P. et al. Equivalent effect of the generic and the reference atorvastatin on the modifiable factors composing the calculated abcolute coronary risk. 75th Congress of European Atherosclerosis Society 23-24 April, 2005, Prague.

Bonner G., Preis S., Schunck U. еt al. Hemodynamic effects of bradykinin on systemic and pulmonary circulation in healthy and hypertensive humans. J Cardiovasc Pharmacol 1990;15 (suppl 6): 46-56.

Bonventre J.V., Huang Z., Taheri M.R., O. Leary E., Li E., Moskowitz M.A., Sapirstein A. Nature1997 Dec 11; 390(6660): 622-5.

Booz G.W., Baker K.M. Role of type 1 and type 2 angiotensin receptors in angiotensin 2-induced cardiomyocyte hypertrophy. Hypertension. 1996; 28: 635-640.

Borroni B., Cottini E., Akkawi N. et al. Is vascular cognitive impairment reversible? Evidence from a study on the effect of carotid endarterectomy // Third International Congress on Vascular Dementia. Abstracts. Prague, 2003. P. 9.

Boyan B.D., Bonewald L.F., Sylvia V.L., Nemere I., Larsson D., Norman A.W., Rosser J., Dean D.D. and Schwartz Z. (2002) Steroids, 67, 421-427.

Brandle M., Davidson M.B., Schriger D.L. et al. Cost effectiveness of statin therapy for the primary prevention of major coronary events in individuals with type 2 diabetes. Diabetes Care. 2003; 26 (6):1796-801.

Braunwald E., Antman E.M., Beasley J.W. et al. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina) // Circulation 2002;106:1893-1900.

Bredt D.S. Nitric Oxide in the Nervous System (Eds. Vincent S.). N.Y. Academic Press. 1995. - P. 1-21.

Bredt D.S. Nitric Oxide Signaling in Brain: Potentiating the Gain with YC-1 //Mol. Pharmacol. 2003; 63, Р. 1206-1208.

Breeders М.А.W., Tangelder G.J., Slaaf D.W. еt al. Hypercholes terolemia enchances tromboembolism in arterioles but not venules: complete reversal by L-arginine. Arterioscler Thromb Vase Biol 2002;22:680-685.

Brehm B.R., Bertsch D., von Falhis J., Wolf S.C. Beta-blockers of the third generation inhibit endothelium-I liberation mRNA production and proliferation of human coronary smooth muscle and endothelial cells. J. Cardiovasc. Pharmacol. 2000, Nov: 36 (5 Suppl.): S401-403.

Brewer L.D., Thibault V., Chen K.C., Langub M.C., Landfield P.W. and Porter N.M. (2001) J. Neurosci., 21, 98-108.

Broillet M.С. // Cell. Мої. Life Sci. - 1999. - 55, N 8-9. - P. 1036-1042. 124.

Bromocriptine reduces lipid peroxidation and enhances spatial learning and hippocampal neuron survival in a rodent model of focal brain trauma / A.E. Kline, J.L. Massucci, X. Ma. et al. // J. Neurotrauma. - 2004. - Vol. 12. - P. 12-22.

Brouet A., Sonveaux P., Dessy С. et al. Hsp90 and caveolin are key tardets for the proangiogenic nitric oxide-mediated effects of statins. Circ Res 2001; 89:866-73.

Brown N.M., Anderson S.A., Steffen D.W. еt al. // Proc. Natl. Acad. Sci. USA. - 1998. - 95, N 26. - P. 15235-15240.

Brown A.J., Dusso A. and Slatopolsky E. (1999) Am. J. Physiol., 277, 157-175.

Brown J., Bianco J.I., McGrath J.J. and Eyles D.W. (2003) Neurosci Lett., 343, 139-143

Brundin L., Svenungsson E., Morcos E. et al. Central nervous system nitric oxide formation in cerebral systemic lupus erythematosus // Ann. Neurol. - 1998. - Vol. 44, № 4. -P. 704-706.

Bruning Т.А., van Zwiete P.A., Blauw G.J., Chang P.C. No functional involvement of 5-hydroxytryptainine la receptors in nitric oxide dependent dilation caused by serotonin in the human forearm vascular bed. J. Cardiovascular Pharmacol. 1994; 24: 454-461.

Buga T.M., Singh R., Peryin S. et al. Arginase activity in endothelial cells: inhibition by hydroxy-L-arginine during high-output NO production. Am J Physiol 1996; 271:H1988-H1998.

Bult H. Nitric oxide and atherosclerosis: possible implications for therapy. Мої Med Today 1996; 2:510-518.

Busse R., Lamontagne D. Endothelium-derived bradykinin is responsible for the increase in calcium produced by angiotensin-converting enzyme inhibitors in human endothelial cells. Naunyn-Schmiedebergs Arch Pharmacol 1991; 344:126-129.

Cabantchik I., Konijn A. // 6th Internet World Congress for Biomedical Sciences February 14-25, 2000 www.uclm.es/inabis2000/symposia/files/181/figurel.htm-Ilk.

Cairo G., Pietrangelo А. // Biochem. J. - 2000. - 352, N 1. - P. 241-250.

Caldwell MA, Reymann JM, Bentue-Ferrer D, Allain H, Leonard BE. Neuropsychobiology 1996; 34(3):117-24.

Callahan A.S. 3rd. Vascular pleiotropy of statins: clinical evidence and biochemical mechanisms. Curr Atheroscler Rep. 2003 Jan;5(1):33-7.

Callaway J.K., Beart P.M., Jarrott B., Giardina S.F. Br J. Pharmacol 2001 Apr 8; 132(8):1691-1698.

Campisi R., Sudhir K., Sievers R.F. et al. L-arginine normalizes coronary vasomotion in long-term smokers. Circulation 1999; 99:491-497.

Canthorna M.T., Hayes C.E. and DeLuca H.F. (1996) Proc. Natl. Acad. Sci. USA, 93, 7861-7864.

Canthorna M.T., Woodward W.D., Hayes C.E. and DeLuca H.F. (1998) J. Immunol., 160, 5314-5319.

Capiati D., Benassati S. and Boland R.L. (2002) J. Cell Biochem, 86, 128-135.

Cardillo C., Kilcoyne С.М., Channon R.O. et al. Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic patients. Hypertension 1997; 30:57063.

Cardiosite.ru (тетрагидробиоптерин).

Carl J., Pepine David S. Celermajer, Helmut Drexler Vascular health as a therapeutic tagert in cardiovascular disease. University of Florida, 1998.

Casino P.R., Kilcoyne C.M., Quyyumi A.A., Hoeg J.M., Panza J.A. The role ot nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients, Circulation, 1993, 88: 2541-2547.

Castillo J., Davalos A., Alvarez-Sabin J, Pumar J.M., Leira R., Silva Y., Montaner., Kase C.S. Neurology 2002 Feb 26; 58(4):624-629.

Cayatte A.J, Palacino J.J., Horten K., Cohen R.A. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb. 1994; 14: 753-759.

Celemajer D.S., Sorensen K.E., Georgakopoulos D. et al. Cigarette smoking is associated witn dose-related and potentially reversible iinpairement of endothelium-dependent dilation in healthy young adults. Circulation, 1993; 88:2140-2155.

Celermajer D.S., Sorenhen K.E., Bull С. Endothelium-dependent dilatation in the systemic arteries of asymptomatic subject relates to coronary risk-factor and thear interaction. J Am Coll Cardiol 1994;24:1468-1474.

Celleti F.L., Waugh J.M., Amabile P.G. et al. Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat Med 2001; 7:425-429.

Ceron P., Cremonez D., Bendhack L., Tedesco А.С. // J. Pharm. Exp. Therap. - 2001. - 298, N 2. - P. 686-694.

Channon K.M., Qian H.S., George S.E. Nitric oxide synthase in atherosclerosis and vascular injury. Insights from experimental gene therapy. Arterioscler Tromb Vase Biol 2000;20:1873-1891.

Chao C.C. et al. Developmental Neuroscience.1995 - 2. - P.97-105.

Chaterjee M. (2001) Mutat. Res., 475, 69-88.

Chatterjee K., Parmley W.W., Ganz W. et al. Haemodynamic and metabolic responses to vasodilator therapy in acute myocardial infarction // Circulation 1973; 48:1183-1193.

Chau R.M.G., Lau I.Y.К.D. // http://www.hku.hk / anatomy / Staff / RMWChau /SOD / Mechanisms%20underlying%20ALS.doc.

Chauhan A., More R.S., Mullins P.A. et al. Ageing-associated endothelial dysfunction in humans is reversed by L-arginine. J Am Coll Cardiol 1996; 28:1796-1804.

Chen L.J., Mehta P., Mehta J.L. Oxidized LDL decreases L-arginine uptake and nitric oxide synthase protein expression in human, platelets: relevance of the effect of oxidized LDL on platelet function. Circulation 1996;93:1740-1746.

Chen X., Liu Z., Wang K., Wang P.G. // J. Biol. Chem. - 2000. - 275, N 27. - P. 20467-20473.

Chen K.B., Lin A.M. and Chiu T.H. (2003) Ann. N.Y. Acad. Sci., 993, 313-324.

Cherchi A. et al. Antianginal and antiischemic activity of nebivolol in stable angina of effort. Drug Invest 1991; 3:Suppl 1:86-98.

Chilian W.M., Eastham C.L., Marcus M.L. Microvascular distribution of coronary vascular resistance in beating left ventricle. Amer. J. Physiol. 1986; 251: 11779-11788.

Chin J.H., Aznar S., Hoffman B.B. Inactivation of endothelial derived relaxing factor by ozidized lipoproteins // J. Clin. Invest. - 1992. - Vol. 89. - P. 10-18.

Chin-Dusting J.P., Alexander С.Т., Arnold P.I. et al. Effects of in vivo and in vitro L-arginine suplementation on healthy human vessels. J Cardiovasc Pharmacol 1996;28:153-166.

Chiu A.T., Herblin W.F., McCall D.E., Ardecky R.J., Duncia J.V., Pease L.J., Wong P.C., Wexler R.R., Johnson A.L., Timmermans P. Identification of angiotensin 2 receptor subtypes. Biochemic. Biophys. Res. Commun. 1989; 165: 196-203.

Choi D.W. Proc. Nath. Acad. Sci USA, 1993, 90. - P.9741.

Chowienczyk P.J., Watts, G.F., Cockroft J.R., Ritter J.M. Impaired endothelium - dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet, 1992; 340: 1430-1432.

Chung O., Unger T. Angiotensin 2 receptor blockade and end organ protection. Amer. J. Hypertension. 1999; 12: 150-156.

Ciampricotti R., Schotborgh C.E., de Kam P.J., van Herwaarden R.H. A comparison of nicorandil with isosorbide mononitrate in elderly patients with stable coronary heart disease: the SNAPE study // Am Heart J 2000; 139:939-943.

Clark G.D., Rothman S.M. Neurosci. 1987. V.21 N.3. P.665-671.

Clark L.T. Treating dyslipidemia with statins: the risk - benefit profile. Am Heart J. 2003 Mar;145(3):387-96.

Clarkson P., Adams M.R., Powe A.J. et al. Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults. J Clin Invest 1996;97:1989-1994.

Clearfield M.B. C-reactive protein: a new risk assessment tool for cardiovascular disease. J Am Osteopath Assoc. 2005 Sep;105(9):409-16.

Clemens, J.A., Ho P.P.K. & Panetta J.A. 1991 Stroke (Dallas) 22, 1048-1052.

Cockcroft J.R., Chowienczyk P.J., Urett S.E., Chen C.P. et al. Nebivolol vasodilated human forearm vasculature, evidence for an L-arginine/NO-dependent mccahanism. J. Pharmacol. Exper. Ther. 1995, Sep; 274(3): 1067-1071.

Coddington J.W., Hurst J.К, Lymar S.V. // J. Am. Chem. Soc. - 1999. - 121. - P. 2438-2443.

Comwell T.L., Arnold E., Boerth N.J., Lincoln T.M. Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Amer. J.Physiol. 1994; 267: C1405-1413.

Consequences of Trauma, Shock and Sepsis. Munich, 2000. Ed: E.Faist, - P.243-248.

Conti C.R. Updated pathophysiologic concepts in unstable coronary artery disease. Am Heart J 2001; 141 (2 Suppl): S12-14.

Cooke J.P, Tsao P.S. Is NO an endogenous antiathero-genic molecule? Arterioscler. Thromb. 1994; 14: 653-655.

Cooke J.P. (1996). Role of nitric oxide in progression and regression of atherosclerosis. West J. Med., 164(5): 419-424.

Cooke J.P. A novel mechanism for pulmonary arterial hypertension? // Circulation, 2003. - №108, Vol. 12. - Р.1420-1421.

Cooke J.P. Antiatherosclerotic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest 1992; 90:1168-1172.

Cooke J.P. Does ADMA cause endothelial dysfunction. Arterioscler Thromb Vase Biol 2002; 20:2032-2045.

Cooke J.P. Flow, NO and atherogenesis. Proc Natl Acad Sci 2003;100:768-770.

Cooke J.P., Dzau V.J. Nitric oxide synthase: role in the genesis of vascular disease. Ann Rev Med 1997;48:489-509.

Cooper С.E. // Biochim. Biophys. Acta. -1999. - 1411, N 2-3. - P. 290.

Cornet A., Baudet C., Neveu I., Baron-Van Evercooren A., Brachet P. and Naveilhan P. (1999) J. Neurosci. Res., 53, 742-746.

Cornwell T.L., Ceaser E.K, Li J. et al. // Am. J. Physiol. Cell Physiol. - 2003. - 284, N 6. - P. C1516-C1524.

Correia S., Brennan-Krohn T., Schlicting E. et al. Diffusion-tensor imaging in vascular cognitive impairment and mild cognitive impairment: relationship with executive functioning // 2nd Congress of the International Society for Vascular Behavioural and Cognitive Disorders (Vas-Cog). Abstract book. Florence, 2005. P. 88.

Cosentino F., Hishikawa K., Katusic Z.S., Luscher T.F. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cell. Circulation 1997; 96:25-28.

Cosentino F., Katusic Z. S. // Circulation. 1995. 966. P. 139-144.

Cosentino F., Sill J., Kanusle Z. Role of superoxide anion in the mediation of endothelium-dependent contraction. Hypertension 1994;23:229-235.

Costa A., Poma A., Navarra P., Forsling M.L., Grossman A. Gaseous transmitters as new agents in neuroendocrine regulation //Journal of Neuroendocrinology. 1997; 149, Р. 199-207.

Cotter G., Faibel H., Barash P. et al. High-dose nitrates in the immediate management of unstable angina: optimal dosage, route of administration, and therapeutic goals // Am J Emerg Med 1998; 16(3):219-224.

Cotter G., Metzkor E., Kaluski E. et al. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema // Lancet 1998; 351:389-393.

Coupe P.J., Williams D.L.H. // J. Chem. Soc. Perkin Trans. - 2001. - 2. - P. 1595-1599.

Courville K.A., Lavie C.J., Milani R.V. Lipid-lowering therapy for elderly patients at risk for coronary events and stroke. Am Heart Hosp J. 2005 Fall;3(4):256-262.

Crane M.S., Ollosson R., Moore K.P. et al. // J. Biol. Chem. - 2002. - 277, N 49. - P. 46858-46863.

Crcager M.A., Gallagher S.J., Girerd X.J. et al. L-arginine improves endothelium-dependent vasodilation in hypercholcsterolcrnic humans. J. Clin. Invest., 1992: 90: 1242-1253.

Crisby M. Modulation of the inflammatory process by statins. Timely Top Med Cardiovasc Dis. 2005 Mar 1; 9:E3.

D'Hellencourt C.L., Montero-Menei C.N., Bernard R. and Couez D. (2003) J. Neurosci. Res., 71, 575-582.

Daly C.A., Clemens F., Sendon J.L. et al. The clinical characteristics and investigations planned in patients with stable angina presenting to cardiologists in Europe: from the Euro Heart Survey of Stable Angina // Eur Heart J 2005; 26:996-1010.

Danysz W., Parsons C.G., Mobius H.-J. et al. Neuroprotective and synptomatological action of memantine relevant for Alzheimer's disease - A unified glutamatergic hypothesis on the mechanism of action // Neurotox. Res. 2000. Vol. 2. P. 85-97.

Darius H. Role of nitrates for the therapy of coronary artery disease patients in the years be-yond 2000 // J Cardiovasc Pharmacol 1999 Aug; 34 Suppl 2:S15-20; discussion S 29-31.

Davalos A., Fernandez-Real J.M., Ricart W. 1994. Stroke 24: 1543-1546.

Davies K.J., Delsignore M.E., LinS.W. (1987) Protein damage and degradation by oxygen radicals. II. Modification of amino acids. J. Biol. Chem., 262(20): 9902-9907.

Davies M.G., Fulton G.J., Haggen P.O. // Brit. J. Surg. - 1995. - Vol. 82. - P. 1598-1610.

Davies M.J., Thomas А.С. Plaque fissuring - the cause of acute myocardial infarction, sudden ischemic death, and creshendo angina. Brit. Heart Journ., 1985: 53: 363-373.

Davis S.F., Yeung A.C., Meridith I.T. et al. Early endothelial dysfunction predicts the development ottransplant coronary artery disease at I year posttransplant. Circulation 1996; 93: 457-462.

Dawson V., Dawson T., Bartley D. et al. Mechanisms of nitriс oxide mediated neurotoxicity in primary brain cultures. //J. Neurosci. - 1993. - Vol.13, №7. - P. 2651-2661.

De Deyn P.P., Reuck J.D., Deberdt W., Vlietinck R., Orgogozo J.M. Stroke 1997 Dec;28(12):2347-52

De Graaf J.C., Banga J.D., Moncada S. et al. Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation, 1992; 85: 2284-2290.

De Leeuw F.-E., van Gijn J. Vascular dementia // Practical Neurology. 2003. Vol. 3. P. 86-91.

De Maria F., Pedersen J.Z., CaccuriA. M. et al. // J. Biol. Chem. - 2003. - 278, N 43. - P. 42283-42293.

De Groot M., Brecht M., Machicao F. Evidence for a factor protective against hypoxic parenchymal cell injury in a protein free blood extract // Res commun Cherm Pathol Pharmacol. 1990. V.68. P. 125-128.

Del Zoppo G., Ginis I., Hallenbeck J.M., Iadecola C., Wang X., Feuerstein G.Z.. Brain Pathol 2000 Jan; 10(1): p95-112.

Delbarre B., Delbarre G., Rochat C., Calinon F. Mol Chem Neuropathol 1995 Sep; 26(1):43-52.

De Pace N., Herling I.M., Kotler M.N. et al. Intravenous nitroglycerin for rest angina. Potential pathophysiologic mechanisms of action // Arch Intern Med 1982; 142:1806-1809.

Desmond D.W. Vascular dementia // Clin. Neurosci. Res. 2004. Vol. 3. P. 437-448.

Devuyst G., Bogousslavsky J. Recent progress in drug treatment for acute stroke // J. Neurol. Neurosurg. Psychiatr. 1999. Vol. 67. P. 420-425.

Different plasma revels of nitric oxide in arterial and venous blood / E. Cicinelli [et al.] // Clin. Physiol. 1999. Vol. 19(5). P. 440-442.

Ding, Y., Vaziri N. Nifedipine and Diltiazem but Not Verapamil Up-Regulate Endothelial Nitric Oxide Synthase Expression. J. Pharmacol. Exp. Ther. 2000; 292: 606-609.

Dogan A., Eras M.A., Raghavendra Rao V.L., Dempsey R.J. Protective effects of memantine against ischemia-reperfusion injury in spontaneously hypertensive rats // Acta Neurochir. (Wien). 1999. Vol. 141. P. 1107-1113.

Dohi Y., Criscione L., Pfeiffer K., Luscher T.F. Angiotensin blockade or calcium antagonists improve endothelial dysfunction in hypertension: studies in perfused mesenteric resistence arteries. J. Cardiovasc Pharmacol 1994; 24:372-9.

Drapier J-C. // Methods in Enzymology. - 1997. - 11. -

P. 319-329.

Drew В., Leluwenburch C. Ageing and the role of reactive nitrogen species. Ann N J Acad Sci 2002; 959:66-81.

Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial disfunction in coronary microcirculation of hypercholesterolemic patients by L-arginine. Lancet, 1991; 338: 1546-1550.

Dugan L.L., Choi D.W. (1994) Excitotoxicity, free radicals and cell membrane changes. Ann. Neurol., 35(Suppl. S): 17-21.

Dupuis J. Mechanisms of acute coronary syndromes and the potential role of statins. Atheroscler Suppl 2001; 2:9-14.

Durzan D.J. // J. Forest Science. - 2002. - N 7. - P. 281-291.

Dzau V.J., Gibbons G.H. Endothelium and growth factors in vascular remodelling of hypertension. Hypertension, 1991: 18 suppl. III: III-115-III-121.

Eaton P., Jones M.E, McGregor M. et al. // J. Am. Soc. Nephrol. - 2003. - 14, N 3. - P. S290-S296.

Eberly L.E., Neaton J.D., Thomas A.J. et al. Multiple-stage screening and mortality in the Multiple Risk Factor Intervention Trial. Clin Trials. 2004; 1(2):148-161.

Ebert B., Mikkelsen S., Thorkildsen C., Borgbjerg F.M. Eur J Pharmacol 1997 Aug 20; 333(1):99-104 Related Articles, Books.

Eddahibi S., Adnot S., Corvil С. et al. L-arginine restores endothelium dependent relaxation in pulmonary circulation of chronically hypoxic rats. Am J Physiol Lung Cell Мої Physiol 1992; 263:L194-L200.

Effect of mellitin on the Central Nervous System / I. Ishay [et al.] // Toxicol. 1975. Vol. 13(4). P. 277-283.

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Inter-vention Trial in Congestive Heart Failure (MERIT-HF) // Lancet 1999; 353:2001-2007.

Egashira K., Inou T., Hirooka Y., Yamada A. et al. Evidence of impaired endothclium-dependent coronary vasodilation in patients with angina pectoris and normal coronary angiograins. New Engl. J. Mod. 1993; 328: 1659-1664.

Ehrlich M., Knolle E., Ciovica R. et al. Memantine for prevention of spinal cord injury in a rabbit model // J. Thorac. Cardiovasc. Surg. 1999. Vol. 117. P. 285-291.

Eide K., Stubhaug A., Oye I., Breivik H. Pain 1995 May; 61(2):221-228 Related Articles, Books, LinkOut

Eiserich J.P., Hristova M., Cross С.E. et al. // Nature. - 1998. - 391, N 6665. - P. 393-397.

Elkayam U., Johnson J.V., Shotan A. et al. Double-blind, placebo-controlled study to evaluate the effect of organic nitrates in patients with chronic heart failure treated with angiotensin-converting enzyme inhibition // Circulation 1999; 99:2652-2657.

Elkayam U., Johnson J.V., Shotan A. et al. Intermittent large dose nitrates added to standard therapy, improves left ventricular function and exercise capacity in patients with chronic heart failure [abstr] // J Am Coll Cardiol 1999; 33:188A.

Elkayam U., Weber L., McKay C., Rahimtoola S. Spectrum of acute hemodynamic effects of nifedipine in severe congestive heart failure // Am J Cardiol 1985; 56:560-566.

Emanuelsson H., Ake H., Kristi M., Arina R. Effects of diltiazem and isosorbide-5-mononitrate, alone and in combination, on patients with stable angina pectoris // Eur J Clin Phar-macol 1989; 36:561-565.

Emerson M., Momi S., Paul W., Alberti P.F. et al. Endogenous nitric oxide acts as a natural antithrombotic agent in vivo by inhibiting platelet aggregation in the pulmonary vasculature. Thromb Haemost 1999; 81:961-966.

Enari M., Sakahira H., Yokoyama H., Okawa K., Iwamatsu A., Nagata S. 1998 Nature 391 (6662), 43-50.

Erben R.G., Soegiarto D.W., Weber K., Zeitz U., Lieberherr M., Gniadecki R., Moller G., Adamski J. and Balling R. (2002) Mol. Endocrinol., 16, 1524-1537.

Erkinjuntti T., Inzitari D., Pantoni L. еt al. Research criteria for subcortical vascular dementia in clinical trials // J. Neural. Transm. 2000. Suppl. 59. P. 23-30.

Erkinjuntti T., Roman G., Gauthier S. et al. Emerging therapies for vascular dementia and vascular cognitive impairment // Stroke. 2004. Vol. 35. P. 1010-1017.

Erkinjuntti T., Roman G., Gauthier S. Treatment of vascular dementia-evidence from clinical trials with cholinesterase inhibitors // J Neurol Sci. 2004. Vol. 226. P. 63-66.

Espey M.G., Miranda K.M., Feelisch M. et al. // Ann. N. Y. Acad. Sci. -2000. - 899. -P. 209-221.

Esposito K., Nappo F., Giugliano G. еt al. Effect of dietary antioxidants on endothelial dysfunction induced by high-fat meel. Am J Clin Nutrition 2003; 77:l:139-143.

Essing M., Nguyen G., Prie D. et al. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins. Circ Res 1998; 83:683-90.

EstevezA. G., Spear N., Manuel S. M. et al. // Ibid. - 1998. - 18, N 3. - P. 923-931.

EstevezA. G., Joaquin J. // Ann. N.-Y. Acad. Sci. - 2002. - 962. -

P. 207-211.

Esther C.R.Jr., Marino E.M., Howard Т.Е. et al. The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice. J. Clin. Invest. 1997: 99: 2375-2385.

Eyles D., Brown J., Mackay-Sim A., McGrath J. and Feron F. (2003) Neurosci., 118, 641-653.

Falk E., Shah P.K., Faster V. Coronary plaque disruption. Circulation, 1995; 92: 657-671.

Farmer J.A., Gotto A.M. Jr. The Heart Protection Study: expanding the boundaries for high-risk coronary disease prevention. Am J Cardiol. 2003 Jul 3;92(1A):3i-9i.

Fassbender K., Hodapp B., Rossol S., Bertsch T., Schmeck J., Schutt S., Fritzinger M., Horn P., Vajkoczy P., Kreisel S., Brunner J., Schmiedek P, Hennerici M. J Neurol Neurosurg Psychiatry 2001 Apr; 70(4):534-537.

Feigin V.L., Rinkel G.J., Algra A., Vermeulen M., van Gijn J. 2000. Cochrane Database Syst Rev 2000; (2):CD000277.

Fenster С.Р., Weinster R.L., Darley-Usmar V.M., Palet R.P. Obesity, aerobic exercise and vascular disease: the role of oxidant stress. Obes Res 2002; 0:964-968.

Ferdinandy P., Schulz R. Nitric oxide, superoxide and peroxinitrite in myocardial ischemia-reperfusion injury and preconditioning. Br J Pharmacol 2003. - 138, N 4. - Р. 532-543.

Feron O., Dessy C., Desager J.P. et al. Hydroxy-methylglutarylconezyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance. Circulation 2001; 103:113-118.

Ferro D, Basili S, Alessandri С et al. Inhibition of tissuefactor- mediated thrombin generation by simvastatin. Atherosclerosis 2000; 149:111-116.

Figueras J., Lidon R., Cortadellas J. Rebound myocardial ischaemia following abrupt interruption of intra-venous nitroglycerin infusion in patients with unstable angina at rest // Eur Heart J 1991;12:405-411.

Fike C.D., Kaplowitz M.R., Thomas C.J. et al. Chronic hypoxia decreases nitric oxide production and endothelial nitric oxide synthase in newborn pig lung. Am J Physiol Lung Cell Мої Physiol 1998; 274:L517-L526.

Finnegan K.T. Neurosci.-N1.-P.14-19 - 1993.

Flather M., Collinson J., Wright A., et al. 71 Practice patterns for patients with unstable angina and myocardial infarction without ST elevation: UK prospective registry of acute ischaemic syndromes (PRAIS-UK) // Lancet 1999; 353(Suppl 3):65.

Folmar S., Oates-Williams F., Sharp P., Reboussin D., Smith J., Cheshire K., Macer J., Klein K.P., Herrington D. Recruitment of Participants for the Estrogen Replacement and Atherosclerosis (ERA) Trial. A Comparison of Costs, Yields and Participant Characteristics from Community- and Hospital-Based Recruitment Strategies. Control Clin Trials 2001; Feb; 22(1):13-25.

Folstein M.F., S.E. Folstein, P.R. McHugh. Mini-Mental State: a practical guidefor grading the mental state of patients for the clinician // J Psych Res. 1975. V. 12. P. 189-198.

Ford W.R., Clanachen A.S., Jugdutt B.I. Opposite effect of angiotensin AT1 and AT2 receptor antagonists on recovery of mechanical function after ischemia-reperfusion in isolated working rat heats. Circulation. 1996; 94: 3087-3089.

Forrete F., Seux M., Staessen J. et al. Prevention of dementia in randomized double blind placebo controlled Systolic hypertension in Europe (Syst-Eur trial) // Lancet. 1998. V. 352. P. 1347-1351.

Fox K., Garcia M.A., Ardissino D. et al. Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology // Eur Heart J 2006; 27:1341-1381.

Franco O.H., Peeters A., Looman C.W. et al. Cost effectiveness of statins in coronary heart disease. J Epidemiol Community Health. 2005 Nov;59(11):927-933.

Frank P.G., Woodman S.E., Park D.S., Lisanti M.P. // Arterioscler. Thromb. Vase. Biol. 2003. Vol. 23, N 7. P. 1161-1168.

Freo U., Pizzolato G., Dam M. et al. A short review of cognitive and functional neuroimaging studies of cholinergic drugs: implications for therapeutic potentials // J. Neural. Transm. 2002. Vol. 109. P. 857-870.

Frisoni G.B., Galluzzi S., Bresciani L. еt al. Mild cognitive impairment with subcortical vascular features. Clinical characteristics and outcome // J. Neurol. 2002. Vol. 249. P. 1423-1432.

Frohlich E.D., Tarazi R.C. Is arterial pressure the sole factor responsible for hypertensive cardiac hypertropliy? Amer. J. Cardiol. 1979: 44: 959-963.

Frohlich E.D. Overview of hemoilynamic factors associated with left ventricular hypertrophy. J. Mol. Cell. Cardiol., 1989: 21: 3-10.

Fu C., Chute D.J., Farag E.S., Garakian J. et al. Comorbidity in dementia: an autopsy study // Arch Pathol Lab Med. 2004. Vol. 128. № 1. P. 32-38.

Fujiwara N., Osanai T., Kamada T., Katoh T., Takahashi K., Okumura K. Study on the relationship between plasma nitrite and nitrate level and salt sensitivity in human hypertension: modulation of nitric oxide synthesis by salt in take Circulation 2000 Feb 29; 101(8):856-861.

Fumiyuki Yamakura, Hikari Така, Tsutomu Fujimura, Kimie Murayama // J. Biol. Chem. --1998. - 273, N 23. - P. 14085-14089.

Furchgott R.F., Zawadszki J.V. The obligatoryrole of endotnelial cells in the relazation of arterial smooth muscle by acetylcholine. Nature. 1980: 288: 373-376.

Furchgott R.F., Vanhoutte P.M. Endothelium-derived relaxing and contracting factors. FASEB J. 1989; 3: 2007-2018.

Fuster V., Lewis A. Mechanisms leading to myocardial infarction: Insights from studies of vascular biology. Circulation, 1994: 90: 2126-2146.

Gahm C., Holmin S., Mathiesen T. Nitric oxide synthase expression after human brain contusion // Neurosurgery. - 2002. - Vol. 50. - P. 1319-1326.

Gai H., Harrison D. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circulat Res 2000; 87:840-844.

Gammage M. Treatment of acute pulmonary oedema: diuresis or vasodilatation? // Lancet 1998; 351:382-388.

Gammage M.D., Murray R.G., Littler W.A. Isosorbide-5-mononitrate in the treatment of acute left ventricular failure following acute myocardial infarction // Eur J Clin Pharmacol 1986; 29:639-643.

Garcion E., Nataf S., Berod A., Darcy F. and Brachet P. (1997) Brain Res. Mol. Brain. Res., 45, 255-267.

Garcion E., Sindji L., Nataf S., Brachet P., Darcy F. and Montero-Menei, C.N. (2003) Acta Neuropathol., 105, 438-448.

Garcion E., Wion-Barbot N., Montero-Menei C.N., Berger F., and Wion, D. (2002) Tr. Endocrinol. Metab., 13, 100-105.

Garnett W. The pharmacology of fluvastatin. Clin. Cardiol., 1994;

17:3-10.

Garthwaite J. Neural Nitric Oxide Signalling // Trends Neurosci. 1995. Vol. 18. P. 51-56.

Gaut J. P., Byun J., Tran H. D. et al. // J. Clin. Invest. - 2002. - 109, N 10. - P. 1311-1319.

Gerhard М., Walsh W., Tawakol А. et al. Estradiol Therapy Combined With Progesterone and Endothelium-Dependent Vasodilation in Postmenopausal Women. Circulation. 1998; 98:1158-1163.

Geroldi C., Ferrucci L., Bandinelli S. et al. Mild cognitive deterioration with subcortical features: Prevalence, clinical characteristics, and association with cardiovascular risk factors in community-dwelling older persons (The InCHIANTI Study) // J. Amer. Ger. Soc. 2003. Vol. 51. P. 1064-1071.

Gerova M. Nitric oxide compromised hypertension: facts and enigmas. Physiol Res 2000; 49:27-35.

Ghadge G.D., Lee J.P., Bindokas V.P. et al. // J. Neurosci. - 1997. - 17, N 15. - P. 8756-8766.

Giannone G., Takeda K, Kleschyov A.L. // J. Physiol. - 2000. - 529, N 3. - P. 735-745.

Gibbons G.H., Dzau V.J. The emerging concept of vascular remodelling. New Engl. J. Med., 1994, 330: 1431-1438.

Gillard S., Boyd T. // Lancet. - 1982. - Vol. 212, N 8. - P. 843-866.

Giraldelo С.М., Zappellini A., Mascara M.N. et al. Effect of L-arginine anologues on rat hind paw oedema and mast cell activation in vitro. Eur J Pharmacol 1994;257:87-93.

Giroud D., Li J.M., Urban P., Meier B., Rutishauer W. Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography. Amer. J. Cardiol. 1992; 69: 729-732.

Giulian D., Corpuz M. J Neurosci Res. - N6. - P. 681-93-1993.

Gladwin M.Т., Schechter A.N. // Circ. Res. - 2004. - 94, N 7. -

P. 851-855.

Glasser S.P. Effect of extended-release isosorbide mononitrate one hour after dosing in pa-tients with stable angina pectoris. IMDUR Study Group // Am J Cardiol 1997; 80(12):1546-1550.

Gobel E.J., Hautvast R.W., van Gilst W.H. et al. Randomised, double-blind trial of intravenous diltiazem versus glyceryl trinitrate for unstable angina pectoris // Lancet 1995; 346:1653-1657.

Gohlke P., Pees C., Unger T. AT2-receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanisms. Hypertension. 1998; 3:349-355.

Gohlke P., Zinz W., Scholkens B.A. et al. Cardiac and vascular effects of long-term losartan treatment in stroke-prone spontaneously hypertensive rats. Hypertension. 1996; 28:397-402.

Goldstein R.E., Boccuzzi S.J., Cruess D., Nattel S. Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Ex-perience Committee; and the Multicenter Diltiazem Postinfarction Research Group // Circulation 1991;83:52-60.

Golomb J., Kluger A., Ferris S.H., Garrand P. Clinician's Manual on Mild Cognitive Impairment. London: Science Press, Ltd. 2001. P. 56.

Gow A.J., Stamler J.S. // Nature. - 1998. - 391, N 6663. -

P. 169-73.

Green L.C., Davic A.W., Golawski J. et al. Analysis of nitrate, nitrite and nitrate in biological fluids // Anal. Biochem. - 1982. - Vol. 126, № 1. -

P. 131-138.

Greenberg D.A. (1987). Ann Neurol 21: 317-3.

Griendling K.K., Minieri C.A., Ollerenshaw J.D. and Alexander R.W. Angiotensin 2 stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res.1994; 74:1141-1148.

Griendling K.K., Ushio-Fuxai M. NADH/NADPH oxidase and vascular function. Trends Cardiovasc Med 1997;7:301-307.

Griendling K.K., Alexander R.W. Oxidative stress and cardiovascular discase. Circulation. 1997; 96: 3264-3265.

Griendling K.K., Minieri C.A., Ollerenshaw J.D., Alexander R.W. Angiotensin II stimulates NADH and NADH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 1994; 74: 1141-1148.

Griendling К.К., Ollerenchaw J.D., Minieri С.А., AlexanderR.W. Angiotensin 2 stimulates NADH and NADPH activity in cultured vascular smooth musele cells. Clin Res 1994;74:1141-1148.

Grines C.L. The role of statins in reversing atherosclerosis: what the latest regression studies show. : J Interv Cardiol. 2006 Feb; 19(1):3-9.

Grisham M.В., Jourd'Heuil D., Wink D.A. //Am. J. Physiol. Gastrointest. Liver Physiol. -1999. - 276, N 2. - P. G315-G321.

Grotta J.C (1999) Acute stroke therapy at the millennium: consummating the marriage between the laboratory and bedside. The Feinberg Eecture. Stroke, 30(8): 1722-1728.

Grunfeld S., Hamilton C., Mesaros S. et al. Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats. Hypertension 1995;26:854-857.

Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction // Lancet 1994; 343:1115-1122.

Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. Six-month effects of early treatment with lisinopril and transdermal glyceryl trinitrate singly and together withdrawn six weeks after acute myocardial infarction: the GISSI-3 trial // J Am Coll Cardiol 1996; 27:337-344.

Guetta V., Quyyumi A.A., Prasad A. et al. The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women. Circulation 1997; 96:2795-801.

Guiliano D., Marfella R., Verazzo G. еt al. The vascular effects of L-arginine in humans: the role of endogenous insulin. J Clin Invest 1997;

99:433-438.

Guillot F., Misslin P., Lemaire M. Comparison of fluvastatin and lovastatin blood-brain barrier transfer using in vitro and in vivo methods. J Cardiovasc. Pharmacol., 1993; 21:339-346.

Guittet O., Ducastel В., Salem J.S. et al. // Ibid. - 1998. - 273, N 34. - P. 22136-22144.

Gustafsson L.E., Leone A.M., Perssn M.G. Endogenous Nitric Oxide is present in the exhaled air of rabbits, guinea and pigs humans // Biochem. Biophys. Res. Com. - 1991. -Vol. 181. - P. 852-857.

Habib A., Creminon C., Frobert Y., Grassi J., Pradelles P. & Maclouf J. (1993) J. Biol. Chem. 268, 23448-23454.

Hachinski V.C., Lassen N.A., Marshall Y. Multi-infarct dementia: a cause of mental deterioration in the elderly // Lancet. 1974. V. 2. P. 207.

Hacket D., Davies G., Maseri A. Pre-existing coronary stenosis in patients with first myocardial infarction are not necessary severe. Europ. Heart J. 1988, 9: 1317-1323.

Haffner S.M. The Scandinavian Simvastatin Survival Study (4S) subgroup analysis of diabetic subjects: implications for the prevention of coronary heart disease. Diabetes Care. 1997 Apr;20(4):469-71.

Hahn A.W., Resink T.J., Scott-Burden T. et al. Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: a novel autocrine function. Cell Regulation. 1990; 1: 649-659.

Halcox J.P., Deanfield J.E. Beyond the laboratory: clinical implications for statin pleiotropy. Circulation. 2004 Jun 1;109(21 Suppl 1):II42-8.

Haley E.C., Kassell N.F., Torner J.C., Truskowski L.L., Germanson TP. 1994. J Neurolog 80:788-796.

Haley E.C., Kassell N.F., Torner J.C. (1993). J neurosurg 78: 537-553.

Hall R., Chong C. A double-blind, parallel-group study of amlodipine versus long-acting nitrate in the management of elderly patients with stable angina // Cardiology 2001; 96:72-77.

Halliwell B., Chirico S. Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr 1993; 57: 715S-725S.

Halliwell B. // FEBS Lett. - 1997. - 411, N 2-3. - P. 157-160.

Hambrecht R., Hilbrich L., Erbs S. et al. Correction of endothelial dysfunction in chronic heart failure: additional effects of exercise training and oral L-arginine supplementation. J Am Coll Cardiol 2000;35:706-713.

Hamson D.G. Endothelial function and oxidant stress. Clin. Cardiol. 1997; 20 (SII): II-11-II-17.

Hanninen T., Hallikainen M., Tuomainen S. et al. Prevalence of mild cognitive impairment: a population-based study in elderly subjects // Acta Neurol. Scand. 2002. Vol. 106. P. 148-154.

Hansson L., Lithell H., Scoog I. et al. Study on cognition and prognosis in the elderly (SCOPE) // Blood Pressure. 1999. V. 8. P. 177-183.

Hanyu H., Tanaka Y., Asano T. et al. Parkinsonism in patients with subcortical arteriosclerotic encephalopathy: A magnetic resonance imaging study // Geriatr. Gerontol. Internat. 2002. Vol. 2. P. 30-35.

Harmon B.V., Corder A.M., Collins R.J., Gobe G.C., Allen J., Allan D.J., Kerr J.F. (1990) Intern. Radiat. Biol. 58, 845-858.

Harnson D.G., Ohara Y. Physiologic consequences of increased vascular oxidant stresses in hypercholesterolemia and atherosclerosis: Implications for impaired vasomotion. Amer. J. Cardiol. 1995, 75: 75B-81B.

...